Application of cartilage extracellular matrix for enhancing the therapeutic efficacy of rheumatoid arthritis drug

被引：0
|
作者：
Seo, JeongWoo [1 ]
Jo, SungHan [1 ]
KIm, SeonHwa [1 ]
Choi, ByeongHoon [1 ]
Park, SangHyug [1 ]
机构：
[1] Pukyong Natl Univ, Busan, South Korea
来源：
TISSUE ENGINEERING PART A | 2022年 / 28卷
关键词：
Rheumatoid Arthritis; Cartilage Extracellular Matrix; Methotrexate; Anti-inflammation;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
PS02-028
引用
收藏
页码：695 / 695
页数：1
相关论文
共 50 条
  • [31] Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy
    Chen, Minglong
    Chen, Bin
    Ge, Xiaoguang
    Ma, Qingjie
    Gao, Shi
    MOLECULAR PHARMACEUTICS, 2023, 20 (05) : 2389 - 2401
  • [32] Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis
    Medina, Frederic
    Plasencia, Chamaida
    Goupille, Philippe
    Ternant, David
    Balsa, Alejandro
    Mulleman, Denis
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 364 - 369
  • [33] Effect of modified extracellular matrix proteins (MECMP) in the inflammation and extracellular matrix turnover in cartilage and synovial tissue co-cultures from patients with osteoarthritts (OA) or rheumatoid arthritis (RA).
    Furuzawa-Carballeda, J
    Muñoz-Chablé, O
    Alcocer-Varela, J
    Díaz-Borjón, E
    Barrios, J
    Hernández-Pando, R
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 407 - 407
  • [34] TAPERING OF ADALIMUMAB BASED ON THERAPEUTIC DRUG MONITORING IN RHEUMATOID ARTHRITIS
    l'Ami, M. J.
    Marsman, A. F.
    Krieckaert, C. L.
    Ruwaard, J.
    Kneepkens, E. L.
    Nurmohamed, M. T.
    Wolbink, G. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1012 - 1012
  • [35] Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?
    Bastida, Carla
    Ruiz, Virginia
    Pascal, Mariona
    Yague, Jordi
    Sanmarti, Raimon
    Soy, Dolors
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 962 - 975
  • [36] Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
    I'Ami, Merel J.
    Marsman, Anneke F.
    Krieckaert, Charlotte L. M.
    Nurmohamed, Mike T.
    Ruwaard, Jill
    Visman, Ingrid M.
    Kneepkens, Eva L.
    Wolbink, Gertjan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [37] Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis
    M. Wisłowska
    B. Jabłońska
    Clinical Rheumatology, 2005, 24 : 278 - 284
  • [38] Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis
    Wislowska, M
    Jablonska, B
    CLINICAL RHEUMATOLOGY, 2005, 24 (03) : 278 - 284
  • [39] THE CORRELATION OF CARTILAGE OLIGOMERIC MATRIX PROTEIN WITH SONOGRAPHIC KNEE CARTILAGE THICKNESS AND DISEASE CHARACTERISTICS IN RHEUMATOID ARTHRITIS
    Rajalngham, S.
    Rajalingam, S.
    Hussein, H.
    Sridharan, R.
    Wahab, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1144 - 1145
  • [40] The Role of the Synovial Fibroblast in Rheumatoid Arthritis Cartilage Destruction and the Regulation of Matrix Metalloproteinases
    Abeles, Aryeh M.
    Pillinger, Michael H.
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2006, 64 (1-2): : 20 - 24
12345